Description
BI 224436 is an investigational new drug under development for the treatment of HIV infection. BI 224436 is the first non-catalytic site integrase inhibitor (NCINI). It inhibits HIV replication via binding to a conserved allosteric pocket of the HIV integrase enzyme. This makes the drug distinct in mechanism of action compared to raltegravir and elvitegravir, which bind at the catalytic site.
Product information
CAS Number: 1155419-89-8
Molecular Weight: 442.51
Formula: C27H26N2O4
Synonym:
BI-224436
Chemical Name: 2-(tert-butoxy)-2-(2-methyl-4-{2-oxa-8-azatricyclo[7.3.1.0⁵,¹³]trideca-1(12),5(13),6,8,10-pentaen-10-yl}quinolin-3-yl)acetic acid
Smiles: CC1=NC2=CC=CC=C2C(=C1C(OC(C)(C)C)C(O)=O)C1=CC=C2OCCC3C=CN=C1C2=3
InChiKey: MIXIIJCBELCMCZ-UHFFFAOYSA-N
InChi: InChI=1S/C27H26N2O4/c1-15-21(25(26(30)31)33-27(2,3)4)23(17-7-5-6-8-19(17)29-15)18-9-10-20-22-16(12-14-32-20)11-13-28-24(18)22/h5-11,13,25H,12,14H2,1-4H3,(H,30,31)
Technical Data
Appearance: Solid Power
Purity: ≥98% (or refer to the Certificate of Analysis)
Shipping Condition: Shipped under ambient temperature as non-hazardous chemical or refer to Certificate of Analysis
Storage Condition: Dry, dark and -20 oC for 1 year or refer to the Certificate of Analysis.
Shelf Life: ≥12 months if stored properly.
Stock Solution Storage: 0 - 4 oC for 1 month or refer to the Certificate of Analysis.
Drug Formulation: To be determined
HS Tariff Code: 382200
Products are for research use only. Not for human use.
Payment & Security
Your payment information is processed securely. We do not store credit card details nor have access to your credit card information.